307,978 Shares in Avantor, Inc. $AVTR Bought by Jupiter Topco LLC

by · The Markets Daily

Jupiter Topco LLC acquired a new stake in Avantor, Inc. (NYSE:AVTR – Free Report) in the second quarter, Holdings Channel reports. The institutional investor acquired 307,978 shares of the company’s stock, valued at approximately $3,047,000.

Other hedge funds have also recently added to or reduced their stakes in the company. BlackRock Inc. bought a new position in Avantor during the second quarter worth about $695,784,000. Wellington Management Group LLP bought a new stake in shares of Avantor in the 4th quarter valued at about $268,584,000. Barrow Hanley Mewhinney & Strauss LLC bought a new stake in shares of Avantor in the 2nd quarter valued at about $195,386,000. Morgan Stanley raised its position in shares of Avantor by 179.4% in the 4th quarter. Morgan Stanley now owns 17,468,418 shares of the company’s stock valued at $200,188,000 after acquiring an additional 11,216,565 shares during the period. Finally, Engine Capital Management LP raised its position in shares of Avantor by 65.8% in the 1st quarter. Engine Capital Management LP now owns 19,780,830 shares of the company’s stock valued at $155,082,000 after acquiring an additional 7,853,018 shares during the period. Institutional investors and hedge funds own 95.08% of the company’s stock.

Avantor Trading Up 3.1%

NYSE:AVTR opened at $14.63 on Thursday. Avantor, Inc. has a fifty-two week low of $7.26 and a fifty-two week high of $15.93. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.78 and a quick ratio of 1.18. The stock has a market capitalization of $9.90 billion, a PE ratio of -17.42, a price-to-earnings-growth ratio of 10.72 and a beta of 0.89. The business’s 50-day simple moving average is $12.42 and its 200-day simple moving average is $9.85.

Avantor (NYSE:AVTR – Get Free Report) last posted its earnings results on Wednesday, July 29th. The company reported $0.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.19 by $0.02. The business had revenue of $1.69 billion during the quarter, compared to analysts’ expectations of $1.61 billion. Avantor had a positive return on equity of 9.92% and a negative net margin of 8.81%.Avantor’s revenue for the quarter was up .5% compared to the same quarter last year. During the same period in the prior year, the business earned $0.24 EPS. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. Sell-side analysts expect that Avantor, Inc. will post 0.81 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

AVTR has been the subject of a number of analyst reports. UBS Group set a $8.00 price objective on shares of Avantor in a report on Wednesday, June 24th. Jefferies Financial Group upgraded shares of Avantor from an “underperform” rating to a “hold” rating and set a $13.00 target price on the stock in a report on Wednesday, July 29th. Wolfe Research raised shares of Avantor from a “strong sell” rating to a “hold” rating in a research report on Thursday, July 30th. Sanford C. Bernstein assumed coverage on shares of Avantor in a report on Friday, June 26th. They issued a “market perform” rating and a $10.50 price target for the company. Finally, Royal Bank Of Canada boosted their price target on shares of Avantor from $9.00 to $14.00 and gave the company a “sector perform” rating in a report on Thursday, July 30th. Two equities research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $12.00.

Check Out Our Latest Stock Report on AVTR

Avantor Profile

(Free Report)

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.

Featured Articles

Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).